Celiac genetic test results in the US: who can see them, and what the law covers
Short answer
Federal law (GINA) covers health insurance and employment but not life, disability or long-term care insurance, so what a genetic test result can touch in the US depends on who is asking1, 2:
- Health insurers may not use genetic information for eligibility, coverage, underwriting or premium decisions under the federal Genetic Information Nondiscrimination Act (GINA)3.
- Employers may not use it in employment decisions, but GINA does not apply to employers with fewer than 15 employees4, 5.
- Life, disability and long-term care insurance fall outside GINA, though some states add protection2.
- A company that sells tests directly to consumers may not be covered by HIPAA, which protects genetic information held by a covered provider, health plan or clearinghouse, so its own privacy statement matters6, 7.
Part of Celiac genetics and family risk, 15 guides

Key points
- GINA reaches health insurance and employment, not life, disability or long-term care insurance2.
- A relative’s test or diagnosis counts as your genetic information under HHS’s definition, so what a family member learns can matter to you too8.
- Some states go further than GINA, and the rules vary widely by state9.
- A test company’s privacy statement can change, and personal information can be transferred if the company is sold, so the statement in force when you read it is not a lasting promise10, 11.
What counts as genetic information
Under the HIPAA Privacy Rule’s definitions (45 CFR 160.103), genetic information is information about your own genetic tests, the genetic tests of family members, the manifestation of a disease or disorder in family members, and any request for or receipt of genetic services, including genetic research participation8.
The EEOC’s description of GINA’s employment rules is similar, and it names family medical history as part of the definition12.
“Family member” is wide: HHS’s definition reaches any first-, second-, third- or fourth-degree relative of the individual or of a dependent of the individual13. A genetic test is defined as an analysis of DNA, RNA, chromosomes, proteins or metabolites that detects genotypes, mutations or chromosomal changes14.
A result from a consumer test counts: NHGRI’s FAQ says the information GINA protects includes the results of genetic tests, direct-to-consumer ones among them15. For celiac disease, NHGRI lists variants in the HLA-DQA1 and HLA-DQB1 genes among the results such tests may report16. What those results do and do not mean for celiac disease is covered in our HLA guide and in our comparison of 23andMe and clinical HLA typing.
A diagnosed disease is treated differently from a gene result. The HHS rule says a disease is “manifested” when a health care professional with the right expertise has diagnosed, or could reasonably diagnose, it, and that it is not manifested if the diagnosis is based principally on genetic information17.
Health insurance: what GINA bars
NHGRI summarizes Title I of GINA this way: health insurers may not use genetic information to decide eligibility, or to make coverage, underwriting or premium-setting decisions3. MedlinePlus says the same law makes it illegal for health insurance providers to use the results of a direct-to-consumer test (or any other genetic test) for decisions about eligibility or coverage1.
The protection extends to private health insurers, Medicare, Medicaid, Federal Employees Health Benefits and the Veterans Health Administration18. For the military’s TRICARE program GINA offers more limited protection19.
GINA also changed HIPAA: NHGRI says it amended HIPAA to make clear that genetic information is health information, in a rule that took effect March 26, 201320. The HHS regulation bars a health plan from using or disclosing protected health information that is genetic information for underwriting purposes, but it excludes issuers of certain long-term care policies from that ban21.
Jobs: what Title II of GINA bars
The EEOC enforces Title II50. It is illegal to discriminate against employees or applicants because of genetic information22, and an employer may never use genetic information in an employment decision, because it is not relevant to a person’s current ability to work4.
Employers also face limits on getting the information at all: it will usually be unlawful for a covered entity to obtain it23, and unlawful to disclose what it holds24.
The EEOC lists narrow exceptions. One is information obtained as part of health or genetic services, including wellness programs, that an employer offers on a voluntary basis, if specific requirements are met25.
Two limits matter to a reader sizing up the protection. GINA does not apply to employers with fewer than 15 employees5, and the US military is permitted to use genetic and medical information in employment decisions26.
Where federal protection stops
| Who is asking | Covered by GINA? | What the source says |
|---|---|---|
| Private health insurer, Medicare, Medicaid, Federal Employees Health Benefits, Veterans Health Administration | Yes18 | May not use genetic information for eligibility, coverage, underwriting or premium-setting3 |
| TRICARE | Limited19 | NHGRI says GINA offers more limited protection19 |
| Employer with 15 or more employees | Yes4, 49 | May never use genetic information in an employment decision4 |
| The US military as an employer | No26 | Permitted to use genetic and medical information in employment decisions26 |
| Employer with fewer than 15 employees | No5 | GINA does not apply5 |
| Life insurance | No27 | Insurers selling these policies have the right to request genetic test results for eligibility, coverage and rates, unless state law prohibits it28 |
| Disability insurance | No27 | Same as life insurance, per MedlinePlus28 |
| Long-term care insurance | No27 | Also excluded from HHS’s ban on using genetic information in underwriting for certain long-term care policies21 |
NHGRI’s clinician FAQ makes the same point about consumer test results: GINA does not provide protections for life, disability or long-term care insurance29.
State laws that add to GINA
NHGRI describes a patchwork of state laws that vary widely in scope, applicability and the amount of protection, with GINA setting a floor and not displacing stricter state laws9.
Some states have laws that go beyond GINA to bar genetic discrimination in “other insurances”, including life, disability and long-term care insurance30. California’s 2011 law, for example, extended protections to emergency medical services, housing, mortgage lending, education and other state-funded programs31.
We did not find a single page that lists every state’s rule, so we do not summarize them here.
HIPAA: a clinician’s record versus a company’s copy
HHS answers the question directly: genetic information is health information protected by the Privacy Rule, but to be protected it must be individually identifiable and maintained by a covered health care provider, health plan or health care clearinghouse6.
NHGRI’s FAQ says ordering and return of direct-to-consumer results typically does not involve a health care professional32. The American Academy of Family Physicians says companies providing these tests may not be bound by standard healthcare privacy protections such as HIPAA7.
What a test company’s own privacy statement decides
MedlinePlus points out that the “terms of use” or “terms of service” are a legally binding agreement between you and the company33. NHGRI adds that, depending on the company, DNA may be used for research or commercial purposes and consent for each use may not be expressly given or understood34.
One company’s statement, read as an example
23andMe’s Privacy Statement, which we read on 2026-11-17, is a worked example of what such a statement can say. It lists insurance companies and employers, public databases, and law enforcement absent a valid court order, subpoena or search warrant among those it will not voluntarily share your personal information with35.
The same statement describes limits and choices. Research use is opt-in36; sharing with genetic relatives is a separate opt-in setting37; and deleting the account opts you out of research and discards the sample38. It also says the company or its genotyping laboratory will keep your genetic information, date of birth and sex where legal obligations such as CLIA require, even if you delete the account39.
In a bankruptcy, merger or sale of assets, the statement says personal information may be accessed, sold or transferred as part of the transaction, and that the statement applies to it as transferred11. It adds that it will not sell or transfer genetic data in such a transaction unless the buyer meets conditions it lists, including agreeing to adopt the statement51. It also says the company may change the statement from time to time10. Its own summary of the law is short: federal and state laws, including GINA, provide some protection from employer and health insurance discrimination40.
One FTC order against a genetic-testing company
One example is an FTC order. In a 2023 decision and order, the Commission determined that it had reason to believe the company, 1Health.io (Vitagene), had violated the Federal Trade Commission Act41; the company neither admitted nor denied the allegations42. The order bars the company from disclosing health information to a third party without the individual’s affirmative express consent, unless required by law43, and tells it to instruct any laboratory that collected physical DNA saliva samples under a contract with it to destroy samples kept more than 180 days after the company accepted the laboratory’s results52. It concerns one company, not a rule for the industry.
Relatives and raw-data services
MedlinePlus notes that people share some DNA with relatives, so what you learn from a consumer test may have implications for family members44. HHS’s definition of genetic information already includes the genetic tests and diagnosed conditions of a person’s relatives8.
Law enforcement is one outside use NHGRI’s FAQ raises: some consumer testing companies have been in the media for allowing law enforcement to access their databases45. The FAQ also flags third-party interpretation services that take raw data files, saying one of the most significant concerns is the lack of informed consent and inconsistent privacy measures46.
Questions MedlinePlus lists before ordering
MedlinePlus lists questions to consider about a company’s privacy policy47. In plain form:
- How does the company protect your genetic data and other personal information, and what happens if its database is hacked?
- What would happen to your sample and data if the company is sold or goes out of business?
- Can you delete your results and data?
- Does the company share or sell customers’ genetic data to pharmaceutical or technology companies, and what is its policy on law enforcement?
- Can you opt out of sharing, selling or research use, or opt out later after agreeing?
- Will you be told if the privacy policy changes?
One further point comes from NHGRI’s clinician FAQ: consumers are not required to share direct-to-consumer results with their insurance professionals48. We found no source that says what any particular application form asks, so check the form and your state’s rules.
Questions people ask
Does GINA cover life insurance?
No. NHGRI says GINA’s health insurance protections do not cover long-term care, life or disability insurance, though some states offer additional protection2.
Can my employer ask for my genetic test results?
The EEOC says it will usually be unlawful for a covered entity to get genetic information, with narrow exceptions such as voluntary wellness programs23, 25. GINA does not apply to employers with fewer than 15 employees5.
Does 23andMe share results with insurers?
Its Privacy Statement says it will not voluntarily share personal information with insurance companies or employers35. That is the company’s statement, not a legal rule, and it says the statement may change10.
Is a result ordered by a doctor protected by HIPAA?
HHS says genetic information is protected by the Privacy Rule when it is individually identifiable and maintained by a covered health care provider, health plan or clearinghouse6.
More in Celiac genetics and family risk
Celiac genetic testing: what HLA-DQ2 and DQ8 results can and cannot tell youWhat HLA-DQ2 and DQ8 typing checks for, how NIDDK, ACG, ESPGHAN and WGO read a negative or positive result, and where the guidelines place the test.
Celiac disease genes beyond HLA: what large genetic studies foundWhat large genetic studies found beyond HLA in celiac disease, how much of the inherited risk those regions explain, and whether clinical tests cover them.
Gone gluten-free without testing: what an HLA gene test can settleWhat an HLA-DQ2/DQ8 gene test can and cannot settle if you stopped gluten before celiac testing, and what sources say a gluten challenge involves.
23andMe versus a clinical HLA test for celiac disease: what each reads and what a negative meansWhich gene variants the FDA-authorized 23andMe celiac report and clinical HLA typing read, and how labs and charities describe a negative or positive.
Screening first-degree relatives for celiac disease: who, when and how oftenWhat the ACG, NICE, BSG, ESPGHAN and NIDDK say about testing parents, siblings and children of someone with celiac disease, and how often.
A positive celiac gene test in your child: what it means and what happens nextWhat a positive HLA (DQ2 or DQ8) result in a child means, why sources say gluten stays in the diet until testing, and what clinicians check next.
Related guides
Does insurance cover celiac testing and dietitian visits in the US?What a US plan pays for celiac blood tests, biopsy and dietitian visits depends on the plan. Reference points, questions to ask and appeal steps.
At-home celiac and gluten sensitivity tests: what they can and cannot showWhat home celiac antibody kits, IgG food panels, stool and genetic tests can and cannot show, and what a result still needs from a clinician.
Travel insurance and finding a doctor abroad with celiac diseaseWhat a travel policy says about pre-existing conditions, the questions to put to an insurer in writing, and where to look for a doctor abroad.
Sources
- [1, 27, 28, 33, 44, 47] MedlinePlus Genetics (National Library of Medicine), What should I know before proceeding with direct-to-consumer genetic testing?, checked Nov 17, 2026.
Read on 2026-11-17: the list headed “Questions to consider about the company’s privacy policies may include:” names how the company protects genetic data and other personal information; what happens if the database is hacked; what would happen to the sample and data if the company is sold or goes out of business; whether results and data can be deleted; whether the company shares or sells customers’ genetic data to pharmaceutical or technology companies; the company’s policy on sharing genetic data with law enforcement; whether you can opt out of sharing, selling or research use; whether you can agree to share and opt out later; and whether you will be notified if the privacy policy changes.
- [2, 3, 5, 9, 18, 19, 20, 26, 30, 31] National Human Genome Research Institute (NIH), Genetic Discrimination, checked Nov 17, 2026.
- [4, 12, 22, 23, 24, 25, 49, 50] US Equal Employment Opportunity Commission, Genetic Information Discrimination, checked Nov 17, 2026.
- [6] US Department of Health and Human Services, Does the HIPAA Privacy Rule protect genetic information?, checked Nov 17, 2026.
- [7] American Academy of Family Physicians, Direct-to-Consumer Genetic Testing (policy), checked Nov 17, 2026.
- [8, 13, 14, 17] eCFR (US Department of Health and Human Services), 45 CFR 160.103, definitions, checked Nov 17, 2026.
- [10, 11, 35, 36, 37, 38, 39, 40, 51] 23andMe, Privacy Statement, checked Nov 17, 2026.
Read on 2026-11-17: the list headed “Who we DO NOT share with:” says 23andMe will not voluntarily share your Personal Information with public databases; insurance companies or employers; and law enforcement, absent a valid court order, subpoena, or search warrant.
- [15, 16, 29, 32, 34, 45, 46, 48] National Human Genome Research Institute (NIH), Direct-to-Consumer Genetic Testing FAQ for Healthcare Professionals, checked Nov 17, 2026.
- [21] eCFR (US Department of Health and Human Services), 45 CFR 164.502, uses and disclosures of protected health information, checked Nov 17, 2026.
- [41, 42, 43, 52] US Federal Trade Commission, Decision and Order, 1Health.io Inc. (Vitagene), docket C-4798, checked Nov 17, 2026.